Eukarys is pleased to announce that it has been awarded Sanofi’s Golden Ticket 2024, which provides one year of free laboratory space at BioLabs France Hôtel-Dieu. We are proud to be the first biomanufacturing technology start-up to receive this prestigious award: all previous winners were in the therapeutic or AI sectors. This recognition underscores the growing importance of biomanufacturing as a key area of innovation within the life sciences industry and confirms the transformative potential of our technology, and the achievability of Eukarÿs’ goal, to accelerate the development of more efficient and cost-effective biomanufacturing solutions, ultimately improving access to critical therapies for patients worldwide.